GRIN1 and schizophrenia: That is not to dispute that NMDA receptor hypofunction is a key feature of schizophrenia (Javitt 2007), and a targeted reduction of GluN1, limited to particular brain regions, particular cell groups, or at a particular stage of development may result in a more selective behavioral model.